Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3015892 | Revista Española de Cardiología | 2007 | 8 Pages |
Abstract
Rosuvastatin improved the lipid profile. Moreover, both rosuvastatin and metformin reduced inflammation and oxidative stress. These results demonstrate the presence of an additional cardioprotective effect, which may result from a direct mechanism of action or be a pleiotropic effect. Further long-term studies are required to determine whether rosuvastatin or metformin can be used to decrease the cardiovascular risk resulting from oxidative stress and inflammation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anel Gómez-GarcÃa, Gloria MartÃnez Torres, Luz E. Ortega-Pierres, Ernesto RodrÃguez-Ayala, Cleto Álvarez-Aguilar,